Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

GSK invests £200m in UK medicine manufacturing

Will upgrade two sites and build centre for manufacturing innovation

- PMLiVE

G8 sets 2025 target for effective dementia treatment

World leaders pledge more research funding

Mobile app formulary and cloud hosting platform launched

IMS Health stakes its claim in mHealth

- PMLiVE

Merck takes Alzheimer’s hope into phase III

MK-8931 moves to late-stage study after positive early data

- PMLiVE

Senior hire for 3D Communications

Allison May Rosen joins as communications lead for FDA Advisory Committee projects

- PMLiVE

Publicis Groupe spending spree continues

Marketing firm buys US-based healthcare analytics firm Verilogue

- PMLiVE

Digital blooms: multichannel marketing in China

The evolution of marketing and its increasing use of new channels is as relevant to China as it is to mature pharma markets

- PMLiVE

Police to probe Novo Nordisk over disclosure delay

Regulator says pharma company was late to announce FDA decision to not approve Tresiba and Ryzodeg

EU flag

EC fines J&J and Novartis in pay-for-delay case

Says companies delayed entry of generic painkiller

- PMLiVE

IMI launches dementia trials alliance

EU group wants to revamp approach to Alzheimer’s research

- PMLiVE

ABPI names NHS partnership manager

Raj Tugnet will lead work to strengthen pharma/NHS collaboration in UK

- PMLiVE

FDA panel backs Takeda’s inflammatory bowel disease drug

Vedolizumab on course for US approval to treat Crohn’s disease and ulcerative colitis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links